Actively Recruiting
PET Imaging of PDE4B Using Radiotracer PF974 in Adults Aged 18 to 70 With PTSD and Alcohol Use Disorder
Led by Yale University · Updated on 2026-06-11
160
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to image the enzyme phosphodiesterase 4B PDE4B in adults with psychiatric disorders such as Post-Traumatic Stress Disorder PTSD and Alcohol Use Disorder AUD, as well as in healthy individuals. The study uses positron emission tomography PET scans combined with the radiotracer 18FPF974 to better understand PDE4B distribution in the brain among these groups. The trial is observational and includes adults aged 18 to 70 years. Participants are divided into four groups those with PTSD, those with AUD, healthy controls without these disorders, and trauma-exposed healthy controls without AUD or PTSD. Each participant undergoes a PET scan using the PF974 radiotracer, which is administered once at baseline. The study does not involve any treatment but focuses on imaging to measure PDE4B. During the study, participants will be assessed once with a PET scan to measure the regional volume of distribution of 18FPF974. Secondary measurements include additional brain region binding of the radiotracer. Participants will be screened for eligibility, and assessments include medical history, physical exams, and laboratory tests. The main outcome is the imaging data collected at baseline, with no ongoing treatment or follow-up required. The study duration and visits vary by participant but focus on a single imaging session.
CONDITIONS
Brief Title
Imaging Phosphodiesterase 4B (PDE4B) in People With Psychiatric Disorders With Positron Emission Tomography (PET) and the Radiotracer [18F]PF974
Research Team
M
Marc V Grasso
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here